

"A specialist clinical research organisation advancing medicines from early to late phase trials"
Simbec-Orion delivers clinical trial management services across all development phases, from first in human studies to pivotal Phase III trials. With specialist expertise in oncology and rare diseases, the company provides flexible, tailored solutions for small to mid-sized biotech and pharmaceutical partners developing innovative medicines for patients with serious unmet medical needs. Operating from clinical pharmacology sites, MHRA accredited Phase I units, and laboratory services across Europe and North America, Simbec-Orion combines comprehensive CRO capabilities with specialist agility and responsiveness. Every study is supported by experienced clinical research, scientific advisory, and biometrics teams dedicated to precise delivery


350
Team Members
1976
Founded
Contract Research
Sector
Hybrid
Work Environment
A world where patients with rare diseases and cancer gain faster access to breakthrough therapies that transform outcomes and save lives
Our passion for improving patients' lives motivates us to apply our skills, experience, and knowledge to advance medicine through flexible, innovative, high quality solutions delivered with integrity